The effect of facial massage aromatherapy on delirium and sleep in patients with acute infarction

Aromatherapy effect of head and face massage on delirium and sleep in patients with acute myocardial infarction hospitalized in cardiac intensive care unit: a parallel randomized clinical trial.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230909059382N1

Enrollment

199

Registered

2024-02-12

Start date

2024-02-04

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: delirium. Condition 2: Sleep. Delirium due to known physiological condition Sleep disorders not due to a substance or known physiological condition

Interventions

Intervention 1: Intervention group 1: After obtaining the necessary letters of recommendation from Shahroud University of Medical Sciences, the researcher will select the patients who meet the criteri

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of acute myocardial infarction (AMI) by a cardiologist. having an acute myocardial infarction for the first time Age over 50 years Hospitalization in the CCU department

Exclusion criteria

Exclusion criteria: Alcohol dependence Vision and hearing problems confirmed by a doctor History of cognitive disorders and psychotic disorders as self-reported by the patient History of taking psychoactive drugs such as anti-anxiety, anti-depressant, mood stabilizer, anti-psychotic drugs The presence of skin problems, wounds and injuries on the patient's head or face Having all kinds of olfactory disorders confirmed by a doctor Suffering from migraine headaches A history of advanced osteoporosis diagnosed by a specialist doctor History of head or face cancer History of allergy to various oils used in massage therapy, such as lavender and sweet almond oil History of seizures and epilepsy Transfer the patient to the ward

Design outcomes

Primary

Measure	Time frame
Delirium. Timepoint: From the evening shift on the second day of hospitalization after the last intervention at the end of the morning shift on the fourth day of hospitalization. Method of measurement: Neelon & Champagn Confusion Scale(NEECHAM) questionnaire.;Sleep. Timepoint: On the morning of the second day of hospitalization at 9 am and on the morning of the third and fourth day of hospitalization at 9 am. Method of measurement: St Mary's Hospital Sleep (SMHSQ ) questionnaire.	—

Measure

Time frame

Delirium. Timepoint: From the evening shift on the second day of hospitalization after the last intervention at the end of the morning shift on the fourth day of hospitalization. Method of measurement: Neelon & Champagn Confusion Scale(NEECHAM) questionnaire.;Sleep. Timepoint: On the morning of the second day of hospitalization at 9 am and on the morning of the third and fourth day of hospitalization at 9 am. Method of measurement: St Mary's Hospital Sleep (SMHSQ ) questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrnaz kharatha

Shahroud University of Medical Sciences

mehrnaz.kharatha@gmail.com+98 23 3239 3811

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026